Monday 29 February 2016

Therapeutic Respiratory Device Market Analysis and Growth

Global therapeutic respiratory devices market is expected to reach USD 19.2 billion by 2022, according to a new report by Grand View Research Inc. Increasing geriatric population contributing towards growing target disease prevalence levels is a key factor expected to attribute towards market growth.
Prevalence of these disorders is expected to constantly rise over the next six years owing to the growing prevalence of cardiovascular disorders, hypertension, obesity, and other lifestyle induced disorders.

Increasing need of emergency treatment for prolonged illnesses and protracted treatment associated with lung diseases in children as well as adults are expected to drive market growth over the next seven years. The introduction of technology innovations is expected to serve as future growth opportunities.

Further key findings from the study suggest:
  • Positive airway pressure devices dominated the product segment in 2014, with market size valued at over 4.0 billion. Growing demand for portable PAP devices and high associated efficacy rates are some key factors expected to drive segment growth.
  • HEPA filtration was the largest technology segment, accounting for over 35.0% of the market share in 2014. High usage of these filters in therapeutic respiratory devices is a major factor contributing towards the segment’s market position.
  • Furthermore, technological advancements in these filters such as the availability of washable HEPA filters and incorporation of HEPA 4 technology is further likely to boost usage rates.
  • Regionally, North America dominated the therapeutic respiratory devices market owing to the presence of high diagnosis rates supported by the presence of sophisticated healthcare infrastructure. Increasing government funding, and the availability of well structured reimbursement framework will also contribute towards healthy market growth.
  • Asia Pacific is expected to witness significant gains, at over 12.0% during the forecast period, driven by the rising incidence of respiratory disorders in the region. Rising healthcare expenditure levels and the presence of high unmet medical need is also a vital growth driver.
  • Key players operating in the therapeutic respiratory devices market include Smiths Medical, GE Healthcare, CareFusion Corporation, Philips Healthcare and Covidien Plc.
  • The market is expected to remain highly competitive, which may see extensive R&D investments aimed at technology innovation, as a widely utilized business strategy.
  • Grand View Research has segmented the global therapeutic respiratory devices market on the basis of products, technology, filters and region:


Product Outlook (Revenue, USD Million, 2012 – 2022)
  • Nebulizers
  • Compressor-based nebulizers
  • Piston-based hand-held nebulizers
  • Ultrasonic nebulizers
  • Humidifiers
  • Heated humidifiers
  • Passover humidifiers
  • Integrated humidifiers
  • Built-in humidifiers
  • Stand-alone humidifiers
  • Oxygen concentrators
  • Fixed oxygen concentrators
  • Portable oxygen concentrators
  • Positive airway pressure devices
  • Continuous positive airway pressure devices
  • Auto-titrating positive airway pressure devices
  • Bi-level positive airway pressure devices
  • Ventilators
  • Adult ventilators
  • Neonatal ventilators
  • Gas Analyzers
  • Capnographs

Technology Outlook (Revenue, USD Million, 2012 – 2022)
  • Electrostatic filtration
  • HEPA filter technology
  • Hollow fiber filtration




Filters Outlook (Revenue, USD Million, 2012 – 2022)

  •  Nebulizer filters
  • Inlet filters
  • Replacement filters
  • Cabinet filters
  • Humidifier filters
  • Wick filters
  • Permanent cleanable filters
  • Mineral absorption pads
  • Demineralization cartridges
  • Positive airway pressure device filters
  • Ultra fine foam inlet filters
  • Polyester non-woven fiber filters
  • Acrylic & polypropylene fiber filters
  • Oxygen concentrators filters
  • HEPA filters
  • Cabinet filters
  • Pre-inlet filters
  • Inlet filters
  • Micro disk filters
  • Felt intake filters
  • Bacterial filters
  • Hollow membrane filters
  • Ventilator filters
  • Mechanical filters
  • HEPA filters
  • ULPA filters
  • Activated carbon filters
  • Electrostatic filters
  • Tribocharged filters
  • Fibrillated filters
·     Regional Outlook (Revenue, USD Million, 2012 – 2022)
  • North America
  • U.S.
  • Canada
  • Europe
  • Spain      
  • Germany
  • France
  •  Italy
  • Switzerland
  • Asia Pacific
  • India
  • Japan
  • China
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa (MEA)
  • South Africa




About Grand View Research

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

Contact:

Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com

Blood Gas And Electrolyte Analyzers Market Growth

Global Blood Gas And Electrolyte Market is expected to reach USD 653.5 million by 2022, according to a new study by Grand View Research Inc. Rising number of patients in ICU and critical care units and increasing demand for high throughput and integrated systems are some key factors likely to drive the blood gas and electrolyte analyzers market. Growing global geriatric population base is also expected to significantly contribute towards market growth over the forecast period, by triggering the incidence rates of target diseases and widening the base of patients requiring critical care. 
The availability of blood gas analyzers has helped enhance the care of critically ill patients allowing for frequent diagnosis and monitoring of respiratory problems and ability to guide prognosis and therapy. Rising demand for technically advanced sleek handheld devices involving short turnaround time has resulted in the development of more compact, sleek, handheld point-of-care devices.

For instance, the OPTI CCA-TS2 blood gas and electrolyte analyzers use innovative optical technology and provide fast results while requiring minimal maintenance.

Global blood gas and electrolyte analyzers market, by product, 2012-2022 (USD Million)



Further key findings from the study suggest:

Portable analyzers dominated the market with a share of over 60.0% in 2014 and are also expected to witness lucrative growth over the forecast period. Growing demand for automated, self-monitoring, portable devices, shorter analysis time, and quick accurate results are key factors boosting the growth of this segment.
Rising need for analyzers, which can analyze blood and electrolyte samples together are swiftly gaining popularity among users.
North America accounted for more than 40% of the blood gas and electrolyte analyzers market in 2014. 

Presence of high unmet needs clubbed with rapidly improving healthcare infrastructure in the emerging markets of India and China is expected to help Asia Pacific grow at a lucrative rate throughout the forecast period. Growing demand for decentralized point-of-care diagnostic facilities handling large volumes of diagnostic tests is also expected to drive regional market growth.
For the purpose of this study, Grand View Research has segmented the blood gas and electrolyte analyzers market on the basis of products, application, end-use, and region:

Global Blood Gas and Electrolyte Analyzers Market, Product Outlook (Revenue, USD Million, 2012 – 2022)
·        Benchtop
·        Portable

Global Blood Gas and Electrolyte Analyzers Market, Application Outlook (Revenue, USD Million, 2012 – 2022)
·        Blood gas analyzers
·        Electrolyte analyzers
·        Combined analyzers

Global Blood Gas and Electrolyte Analyzers Market, End-use Outlook (Revenue, USD Million, 2012 – 2022)
·        Clinical laboratories
·        Point-of-care
Blood Gas and Electrolyte Analyzers Market, Regional Outlook (Revenue, USD Million, 2012 – 2022)
·        North America
·        U.S.
·        Canada
·        Europe
·        Germany
·        France
·        Spain
·        Asia Pacific
·        Japan
·        China
·        Latin America
·        Brazil
·        Mexico
·        Middle East and Africa (MEA)
·        South Africa


About Grand View Research

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

Contact:

Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com

Carcinoembryonic Antigen (CEA) Market Analysis and Segment Forecasts To 2022

Global Carcinoembryonic Antigen market is expected to reach USD 2.56 Billion by 2022, according to a new study by Grand View Research, Inc. Constant technological advancements pertaining to the development of novel biomarkers which can be used in combination with other biomarkers is expected to boost usage rates over the forecast period. 

According to the WHO estimates in 2012, global cancer incidences were nearly 14.1 million, which include 6.7 million female patients and 7.4 million male patients. Increasing demand for minimally invasive diagnostics procedures is also expected to play a vital role in determining market growth. Key advantages associated with minimally invasive diagnostics procedures include elevated patient satisfaction levels as they entail minor incision wounds. In addition, these procedures involve relatively lesser hospital stays and therefore, are economically viable and involve fewer post procedure complications.

Carcinoembryonic antigen market, by application, 2012 – 2022 (USD Million)




Further key findings from the study suggest:
Colorectal cancer was one of the largest revenue generating application segment of the carcinoembryonic antigen market and was estimated at USD 639.65 million in 2014.  Increasing prevalence of colorectal cancer and usage of carcinoembryonic antigen tests at various stages is one of the critical factors accounting for its large share.For instance, in 2012, new cases of colorectal cancer were estimated to be over 93,000 and death due to colorectal cancer is expected to be over 49,700 in the U.S alone.
Carcinoembryonic antigen based breast cancer diagnosis is identified as the most lucrative application segment of the market. The market is driven by factors such as growing number of female population above 50 years, growing demand for Hormone Replacement Therapy (HRT) and cosmetic surgeries. Moreover, growing patient awareness levels and the presence of favorable government initiatives are expected to improve treatment rates over the forecast period.
North America was the largest regional market in 2014 owing to, the presence of high incidence rates, presence of favorable reimbursement framework, and high consumer awareness levels coupled with relatively higher healthcare expenditure levels.

Asia Pacific is anticipated to witness the most lucrative growth over the forecast period. The presence of untapped opportunities, constantly improving healthcare infrastructure, economic development, and improving patient awareness levels are some factors accounting for this rapid growth.
Key players operating in carcinoembryonic antigen market include Abbott Diagnostics, Quest Diagnostics, Roche Diagnostics, GenWay Biotech Inc. and Correlogic Systems, Inc. 

For the purpose of this study, Grand View Research has segmented the carcinoembryonic antigen market on the basis of application, and region:
Carcinoembryonic Antigen Application Outlook (Revenue, USD Million, 2012 – 2022)

·        Colorectal cancer
·        Pancreatic cancer
·        Ovarian cancer
·        Breast cancer
·        Thyroid cancer
·        Others

Carcinoembryonic Antigen Regional Outlook (Revenue, USD Million, 2012 – 2022)

·        North America
·        U.S.
·        Canada
·        Europe
·        Germany
·        France
·        Spain
·        Asia Pacific
·        China
·        Japan
·        India
·        MEA
·        South Africa
·        Latin America
·        Brazil
·        Mexico


About Grand View Research

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

Contact:

Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com

Hearing Amplifiers Market Analysis And Segment Forecasts To 2022

Global Hearing Amplifiers market is expected to reach USD 78.2 million by 2022, according to a new study by Grand View Research Inc. Growing prevalence of deafness and hearing disorders and the increasing cost of hearing aids are expected to drive the hearing amplifiers market over the forecast period. Hearing amplifiers are relatively cheaper products and therefore, are more preferred in patients with manageable deafness severities. For instance, the ASP of hearing amplifier amounts to USD 200, as opposed to hearing aids priced at approximately USD 450 to 1,000. Rising R&D investments aimed at new product development in congruence with the changing consumer dynamics is expected to significantly contribute towards expedited market growth.
Global hearing amplifiers market, by product, 2012-2022 (USD Million)

Further key findings from the study suggest:
On the ear hearing amplifiers were the largest product segment of the market in 2014. The fact that, on the ear hearing amplifiers are comfortable to use, render high connectivity and are user-friendly is expected to drive segment growth over the forecast period.

In the ear hearing amplifiers allow clear perception of surrounding voice as it blocks the entire ear cavity and prohibit the passage of the user’s own voice and this is expected to serve the segment as a driver. Moreover, these devices score high on the consumer preference matrix owing to their aesthetic appeal.
Asia Pacific is expected to spearhead future market growth.
The increasing prevalence of deafness especially in the geriatric population and growing retail healthcare industry in emerging countries such as India and China are some factors attributing to region’s rapid market growth.

According to the United Nations study of 2007, by 2025, 64 elderly for every 100 workers is the estimated ratio in China. In 2003, as per a study of the United Nations Children's Fund (UNICEF), approximately 10% of the population had hearing loss. The Second China National Survey on Disability by the China Disabled Persons' Federation (CDPF) identified 20.04 million people as “hearing impaired”. Growing population in China and introduction of technologically advanced devices are expected to drive the market over the forecast period.
Key players of the hearing amplifiers market include Resound, SoundHawk, Shenzhen LA Lighting Company Limited, Austar Hearing Science And Technology (Xiamen) Co., Ltd., Ziphearing and Huizhou Jinghao Electronics Co. Ltd.

Grand View Research has segmented the hearing amplifiers market on the basis of products:
Global Hearing Amplifiers Market, Product Outlook (Revenue, USD Million, Volume (Number of Units), USP (Price/Unit) 2012 – 2022)

·       On-the-Ear/On the ear
In-the-Ear/ In the ear

Hearing Amplifiers Market, Regional Outlook (Revenue, USD Million, Volume (Number of Units), USP (Price/Unit) 2012 – 2022)
·        North America
·        U.S.
·        Canada
·        Europe
·        UK
·        Netherlands
·        Germany
·        Norway
·        Sweden
·        Spain
·        Denmark
·        Switzerland
·        Italy
·        France
·        Russia
·        Others
·        Asia Pacific
·        Japan
·        China
·        India
·        Australia
·        New Zealand
·        Others
·        RoW
·        Brazil
·        Others


About Grand View Research

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

Contact:

Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com